These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 17573840)
21. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults. Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388 [TBL] [Abstract][Full Text] [Related]
22. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Jackson LA; Jackson ML; Nelson JC; Neuzil KM; Weiss NS Int J Epidemiol; 2006 Apr; 35(2):337-44. PubMed ID: 16368725 [TBL] [Abstract][Full Text] [Related]
23. Effectiveness of pneumococcal vaccination in older adults with chronic respiratory diseases: results of the EVAN-65 study. Ochoa-Gondar O; Vila-Corcoles A; Ansa X; Rodriguez-Blanco T; Salsench E; de Diego C; Raga X; Gomez F; Valdivieso E; Fuentes C; Palacios L; Vaccine; 2008 Apr; 26(16):1955-62. PubMed ID: 18343541 [TBL] [Abstract][Full Text] [Related]
24. Impact of influenza vaccination on major cause-specific mortality. Wang CS; Wang ST; Lai CT; Lin LJ; Chou P Vaccine; 2007 Jan; 25(7):1196-203. PubMed ID: 17097773 [TBL] [Abstract][Full Text] [Related]
25. Influenza vaccination coverage and related factors among Spanish patients with chronic obstructive pulmonary disease. Jiménez-García R; Ariñez-Fernandez MC; Garcia-Carballo M; Hernández-Barrera V; de Miguel AG; Carrasco-Garrido P Vaccine; 2005 May; 23(28):3679-86. PubMed ID: 15882528 [TBL] [Abstract][Full Text] [Related]
27. Compliance with influenza and pneumococcal vaccination among patients with chronic obstructive pulmonary disease consulting their medical practitioners in Catalonia, Spain. Jiménez-García R; Ariñez-Fernandez MC; Hernández-Barrera V; Garcia-Carballo MM; de Miguel AG; Carrasco-Garrido P J Infect; 2007 Jan; 54(1):65-74. PubMed ID: 17049991 [TBL] [Abstract][Full Text] [Related]
28. Could a federal program to promote influenza vaccination among elders be cost-effective? Patel MS; Davis MM Prev Med; 2006 Mar; 42(3):240-6. PubMed ID: 16480761 [TBL] [Abstract][Full Text] [Related]
29. Impact of influenza vaccination on seasonal mortality in the US elderly population. Simonsen L; Reichert TA; Viboud C; Blackwelder WC; Taylor RJ; Miller MA Arch Intern Med; 2005 Feb; 165(3):265-72. PubMed ID: 15710788 [TBL] [Abstract][Full Text] [Related]
30. Influenza vaccination health impact and cost effectiveness among adults aged 50 to 64 and 65 and older. Maciosek MV; Solberg LI; Coffield AB; Edwards NM; Goodman MJ Am J Prev Med; 2006 Jul; 31(1):72-9. PubMed ID: 16777545 [TBL] [Abstract][Full Text] [Related]
31. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. Nichol KL; Nordin J; Mullooly J; Lask R; Fillbrandt K; Iwane M N Engl J Med; 2003 Apr; 348(14):1322-32. PubMed ID: 12672859 [TBL] [Abstract][Full Text] [Related]
32. Retrospective assessment of influenza vaccine effectiveness among the non-institutionalized elderly population in Japan. Ozasa K; Kawahito Y; Doi T; Watanabe Y; Washio M; Mori M; Kase T; Maeda A; Hirota Y Vaccine; 2006 Mar; 24(14):2537-43. PubMed ID: 16417955 [TBL] [Abstract][Full Text] [Related]
33. Prevalence and predictors of influenza vaccination among frail, community-living elderly patients: an international observational study. Landi F; Onder G; Carpenter I; Garms-Homolova V; Bernabei R Vaccine; 2005 Jun; 23(30):3896-901. PubMed ID: 15917110 [TBL] [Abstract][Full Text] [Related]
34. [Influenza vaccination in the elderly: effectiveness not in doubt]. Hak E; Opstelten W; Looijmans-van den Akker I; Knottnerus JA Ned Tijdschr Geneeskd; 2008 May; 152(19):1081-3. PubMed ID: 18552059 [TBL] [Abstract][Full Text] [Related]
35. Determinants of influenza vaccination among the adult and older Italian population with chronic obstructive pulmonary disease: a secondary analysis of the multipurpose ISTAT survey on health and health care use. Chiatti C; Barbadoro P; Marigliano A; Ricciardi A; Di Stanislao F; Prospero E Hum Vaccin; 2011 Oct; 7(10):1021-5. PubMed ID: 21941094 [TBL] [Abstract][Full Text] [Related]
36. Adverse effects associated with influenza vaccination in patients with COPD: a randomized controlled study. Wongsurakiat P; Maranetra KN; Gulprasutdilog P; Aksornint M; Srilum W; Ruengjam C; Sated W Respirology; 2004 Nov; 9(4):550-6. PubMed ID: 15612969 [TBL] [Abstract][Full Text] [Related]
37. Late influenza vaccination is associated with reduced effectiveness. Chodick G; Heymann AD; Green MS; Kokia E; Shalev V Prev Med; 2006 Jul; 43(1):71-6. PubMed ID: 16595150 [TBL] [Abstract][Full Text] [Related]
38. Burden of influenza-like illness and effectiveness of influenza vaccination among working adults aged 50-64 years. Nichol KL; D'Heilly SJ; Greenberg ME; Ehlinger E Clin Infect Dis; 2009 Feb; 48(3):292-8. PubMed ID: 19115970 [TBL] [Abstract][Full Text] [Related]
39. Decline in influenza-associated mortality among Dutch elderly following the introduction of a nationwide vaccination program. Jansen AG; Sanders EA; Nichol KL; van Loon AM; Hoes AW; Hak E Vaccine; 2008 Oct; 26(44):5567-74. PubMed ID: 18722492 [TBL] [Abstract][Full Text] [Related]
40. [Vaccination against influenza--why, for whom and with which vaccine?]. Bergsaker M; Hungnes O; Iversen B Tidsskr Nor Laegeforen; 2006 Nov; 126(21):2814-7. PubMed ID: 17086223 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]